Smyth EM - Search Results

1

Editorial: Eicosanoids in cancer, Volume II.

Patrignani P, Smyth EM, Ricciotti E. Patrignani P, et al. Among authors: smyth em. Front Pharmacol. 2023 Jun 14;14:1224623. doi: 10.3389/fphar.2023.1224623. eCollection 2023. Front Pharmacol. 2023. PMID: 37388454 Free PMC article. No abstract available.

2

Editorial: Eicosanoids in Cancer.

Markosyan N, Smyth EM, Patrignani P, Ricciotti E. Markosyan N, et al. Among authors: smyth em. Front Pharmacol. 2021 Sep 9;12:765214. doi: 10.3389/fphar.2021.765214. eCollection 2021. Front Pharmacol. 2021. PMID: 34566667 Free PMC article. No abstract available.

3

COX-2 mediates pro-tumorigenic effects of PKCε in prostate cancer.

Garg R, Blando JM, Perez CJ, Lal P, Feldman MD, Smyth EM, Ricciotti E, Grosser T, Benavides F, Kazanietz MG. Garg R, et al. Among authors: smyth em. Oncogene. 2018 Aug;37(34):4735-4749. doi: 10.1038/s41388-018-0318-9. Epub 2018 May 16. Oncogene. 2018. PMID: 29765153 Free PMC article.

4

Prostacylin receptor activation inhibits proliferation of aortic smooth muscle cells by regulating cAMP response element-binding protein- and pocket protein-dependent cyclin a gene expression.

Kothapalli D, Stewart SA, Smyth EM, Azonobi I, Pure E, Assoian RK. Kothapalli D, et al. Among authors: smyth em. Mol Pharmacol. 2003 Aug;64(2):249-58. doi: 10.1124/mol.64.2.249. Mol Pharmacol. 2003. PMID: 12869629

5

Glycosylation of the human prostacyclin receptor: role in ligand binding and signal transduction.

Zhang Z, Austin SC, Smyth EM. Zhang Z, et al. Among authors: smyth em. Mol Pharmacol. 2001 Sep;60(3):480-7. Mol Pharmacol. 2001. PMID: 11502878

6

The G12 family of G proteins as a reporter of thromboxane A2 receptor activity.

Zhang L, DiLizio C, Kim D, Smyth EM, Manning DR. Zhang L, et al. Among authors: smyth em. Mol Pharmacol. 2006 Apr;69(4):1433-40. doi: 10.1124/mol.105.019703. Epub 2006 Jan 17. Mol Pharmacol. 2006. PMID: 16418336

7

The physical association of the P2Y12 receptor with PAR4 regulates arrestin-mediated Akt activation.

Khan A, Li D, Ibrahim S, Smyth E, Woulfe DS. Khan A, et al. Mol Pharmacol. 2014 Jul;86(1):1-11. doi: 10.1124/mol.114.091595. Epub 2014 Apr 10. Mol Pharmacol. 2014. PMID: 24723492 Free PMC article.

8

Targeting COX-2 abrogates mammary tumorigenesis: Breaking cancer-associated suppression of immunosurveillance.

Markosyan N, Chen EP, Smyth EM. Markosyan N, et al. Among authors: smyth em. Oncoimmunology. 2014 Jun 30;3:e29287. doi: 10.4161/onci.29287. eCollection 2014. Oncoimmunology. 2014. PMID: 25114833 Free PMC article.

9

Deletion of cyclooxygenase 2 in mouse mammary epithelial cells delays breast cancer onset through augmentation of type 1 immune responses in tumors.

Markosyan N, Chen EP, Ndong VN, Yao Y, Sterner CJ, Chodosh LA, Lawson JA, Fitzgerald GA, Smyth EM. Markosyan N, et al. Among authors: smyth em. Carcinogenesis. 2011 Oct;32(10):1441-9. doi: 10.1093/carcin/bgr134. Epub 2011 Jul 18. Carcinogenesis. 2011. PMID: 21771729 Free PMC article.

10

COX-2 and PGE2-dependent immunomodulation in breast cancer.

Chen EP, Smyth EM. Chen EP, et al. Among authors: smyth em. Prostaglandins Other Lipid Mediat. 2011 Nov;96(1-4):14-20. doi: 10.1016/j.prostaglandins.2011.08.005. Epub 2011 Aug 31. Prostaglandins Other Lipid Mediat. 2011. PMID: 21907301 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page